Your session is about to expire
← Back to Search
Behavioral Intervention
EWM Training for Attention Deficit Hyperactivity Disorder (ADHD)
N/A
Waitlist Available
Led By Michael C Stevens, PhD
Research Sponsored by Hartford Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosis of ADHD
English speaking
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in scores from baseline assessment versus 5 weeks at the conclusion of training
Awards & highlights
Study Summary
This trial will test a new working memory training intervention for ADHD to see if it affects the frontoparietal brain network and behavior.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
You are right-handed.
Select...
You should be able to read and understand material at a level expected of someone who has completed at least 5th grade.
Select...
You need to have an IQ score of at least 80.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change in scores from baseline assessment versus 5 weeks at the conclusion of training
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in scores from baseline assessment versus 5 weeks at the conclusion of training
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Magnetic Resonance Imaging Functional Brain Scan using a Seimens 3T Skyra.
The experimental executive working memory training tasks
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: ADHD EWMExperimental Treatment1 Intervention
Participants will receive EWM training sessions.
Group II: ADHD PlaceboPlacebo Group1 Intervention
Participants will receive placebo training sessions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
EWM Training
2021
N/A
~70
Find a Location
Who is running the clinical trial?
Hartford HospitalLead Sponsor
133 Previous Clinical Trials
18,870 Total Patients Enrolled
1 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
38 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Michael C Stevens, PhDPrincipal InvestigatorInstitute of Living/Hartford Hospital
1 Previous Clinical Trials
40 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger